Literature DB >> 16303780

Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial.

Vincenzo Panichi1, Giovanni Manca-Rizza, Sabrina Paoletti, Daniele Taccola, Cristina Consani, Cristina Filippi, Emanuela Mantuano, Antonino Sidoti, Giovanni Grazi, Alessandro Antonelli, Daniela Angelini, Isabella Petrone, Carlo Mura, Patricia Tolaini, Franco Saloi, Paolo M Ghezzi, Giuliano Barsotti, Roberto Palla.   

Abstract

BACKGROUND: HFR [double chamber haemodiafiltration (HDF) with reinfusion of regenerated ultrafiltrate] is a novel dialytic method which combines the processes of diffusion, convection and adsorbance. In this technique an adsorbent cartridge of resin and charcoal may regenerate the ultrafiltrate suggesting its use as an endogenous substitution fluid. The aim of this multicentre randomized cross-over study was to compare HFR to online HDF in terms of inflammatory and nutritional parameters.
METHODS: After a 1 month run-in period of standard bicarbonate dialysis (HD) with a synthetic membrane, 25 chronic dialytic patients were randomized (A-B or B-A) to be treated by HFR (A) with a two-chamber filter (SG 8 Plus - high permeability Polysulphone HF 0.7 m2 + SMC 1.95 sqm; Bellco, Mirandola, Italy) or by online sterile bicarbonate HDF. Each study period of 4 months was separated by 1 month of HD and the entire length of the study was 10 months. CRP levels were measured by a highly sensitive nephelometric assay (Dade, Behring) with a sensitivity of 0.1 microg/ml. Cytokine concentrations were determined by EIA [Interleukin (IL) 6, Biosource, USA and IL-10 Bender MED-Systems, Vienna]. The sensitivity thresholds were < 5 pg/ml for IL-6 and < 8 pg/ml for IL-10. Serum leptin was determined with a ELISA method (Biosource, USA). All parameters were determined monthly in patients starting a midweek dialytic session.
RESULTS: Plasma CRP and IL-6 were significantly reduced during the 4 months of HFR and HDF: CRP from 8.0 +/- 3.2 to 5.6 +/- 3.4 mg/l with HFR (P < 0.05) and from 9.4 +/- 4.3 to 5.9 +/- 3.9 mg/l with HDF (P < 0.05). IL-6 decreased from 14.8 +/- 6.3 to 10.1 +/- 3.2 with HFR (P < 0.02) and from 12.1 +/- 4.2 to 9.6 +/- 3.7 with HDF (P = ns) with a percentage decrease after 4 months of 32% with HFR vs 21% with HDF. During the 1 month wash-out period with HD, CRP increased from 5.7 +/- 3.6 to 8.7 +/- 3.9 mg/l (P < 0.01) and IL-6 from 10 +/- 3.4 to 13.5 +/- 5.2 pg/ml (P < 0.01). A significant increase in IL-10 was detected either in HFR (from 4.8 +/- 2.1 to 6.89 +/- 1.7 pg/ml) and in HDF (from 3.3 +/- 1.7 to 8.95 +/- 4.3 pg/ml; P < 0.05) after 4 months. No significant variation in serum leptin levels were observed during the study. CRP and IL-6 were highly correlated (r = 0.54; P < 0.001) as was serum albumin and prealbumin (r = 0.39; P < 0.001). Serum albumin was negatively correlated with CRP (r = -0.26; P < 0.01) and IL-6 (r = -0.19; P < 0.05); serum prealbumin was correlated with IL-6 (r = 0.37; P < 0.001) and with CRP (r = 0.24; P < 0.01).
CONCLUSIONS: Haemodiafiltration with online regeneration of ultrafiltrate and online HDF are highly biocompatible techniques and no significant difference between HFR and online HDF was observed in terms of reduction of inflammatory markers. Further studies with a longer follow-up are needed to evaluate the clinical relevance of the online endogenous reinfusion to counteract the chronic inflammatory state of the uraemic patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16303780     DOI: 10.1093/ndt/gfi189

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  8 in total

1.  The effects of 1-year treatment with a haemodiafiltration with on-line regeneration of ultrafiltrate (HFR) dialysis on biomarkers of oxidative stress in patients with chronic renal failure.

Authors:  B González-Diez; M Cavia; G Torres; P Abaigar; V Camarero; P Muñiz
Journal:  Mol Biol Rep       Date:  2011-05-21       Impact factor: 2.316

2.  Secondary hyperparathyroidism and anemia in children treated by hemodialysis.

Authors:  Lorie B Smith; Jeffrey J Fadrowski; Chanelle J Howe; Barbara A Fivush; Alicia M Neu; Susan L Furth
Journal:  Am J Kidney Dis       Date:  2010-02       Impact factor: 8.860

3.  Efficacy of Supra-HFR in Removing FGF23 and Cytokines: A Single Session Analysis.

Authors:  Gabriele Donati; Andrea Angeletti; Maria Cappuccilli; Chiara Donadei; Chiara Guglielmo; Anna Scrivo; Lorenzo Gasperoni; Maddalena Zambelli; Maria Mattiotti; Gaetano La Manna
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

Review 4.  Reconsidering adsorption in hemodialysis: is it just an epiphenomenon? A narrative review.

Authors:  Nans Florens; Fitsum Guebre-Egziabher; L Juillard
Journal:  J Nephrol       Date:  2021-04-10       Impact factor: 3.902

5.  Hemodiafiltration is associated with reduced inflammation, oxidative stress and improved endothelial risk profile compared to high-flux hemodialysis in children.

Authors:  Ayşe Ağbaş; Nur Canpolat; Salim Çalışkan; Alev Yılmaz; Hakan Ekmekçi; Mark Mayes; Helen Aitkenhead; Franz Schaefer; Lale Sever; Rukshana Shroff
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

6.  Online hemodiafilteration use in children: a single center experience with a twist.

Authors:  Magid A A Ibrahim; Ihab Z ElHakim; Dina Soliman; Muhammad A Mubarak; Ragia M Said
Journal:  BMC Nephrol       Date:  2020-07-28       Impact factor: 2.388

7.  Extracorporeal Blood Purification in Moderate and Severe COVID-19 Patients: A Prospective Cohort Study.

Authors:  Rodney Alexander Rosalia; Petar Ugurov; Dashurie Neziri; Simona Despotovska; Emilija Kostoska; Lidija Veljanovska-Kiridjievska; Dimche Kuzmanov; Aleksandar Trifunovski; Dijana Popevski; Gianluca Villa; Zan Mitrev
Journal:  Blood Purif       Date:  2021-06-14       Impact factor: 2.614

8.  Vitamins (A, C and E) and oxidative status of hemodialysis patients treated with HFR and HFR-Supra.

Authors:  Simonetta Palleschi; Paolo M Ghezzi; Giuseppe Palladino; Barbara Rossi; Marino Ganadu; Domenica Casu; Maria Cossu; Giovanni Mattana; Antonio Maria Pinna; Bruno Contu; Tonina Ghisu; Alessandro Monni; Luana Gazzanelli; Maria Cristina Mereu; Franco Logias; Mario Passaghe; Alessandro Amore; Piergiorgio Bolasco
Journal:  BMC Nephrol       Date:  2016-08-26       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.